Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The test item is considered to be a non-sensitizer under the conditions of a local lymph node assay.
No information is available for respiratory sensitization, however, the substance is a waxy solid with a low vapour pressure and therefore respiratory sensitization is considered unlikely.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- The study was conducted between 20 May 2016 and 08 June 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 22 July 2010
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- EC No. 440/2008
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Sponsor Lot/Batch no.: 5399561P10
- Expiration date of the lot/batch: 25 January 2020
- Purity test date: 25 January 2016
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature in the dark - Species:
- mouse
- Strain:
- CBA/Ca
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Envigo RMS B.V., Inc, the Netherlands
- Females (if applicable) nulliparous and non-pregnant: yes
- Microbiological status of animals, when known:
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: 15 - 23 g
- Housing: Suspended solid floor polypropylene cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: >5 days
- Indication of any skin lesions: no
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 - 25 ”C
- Humidity (%): 30 - 70%
- Air changes (per hr): >15
- Photoperiod (hrs dark / hrs light): 12/12
- IN-LIFE DATES: From: 20 May 2016 To: 08 June 2016 - Vehicle:
- propylene glycol
- Concentration:
- Preliminary Screening: 10% w/w in propylene glycol (maximum attainable concentration
Main Test: 10%, 5% and 2.5% w/w in propylene glycol - No. of animals per dose:
- Preliminary screening: 1 mouse
Main test 5 mice /concentration - Details on study design:
- PRE-SCREEN TESTS:
- Compound solubility: Maximum attainable concentration = 10% w/w
- Irritation: scored daily
- Systemic toxicity: not determined
- Ear thickness measurements: Between Days 1 and 3 and Days 1 and 6
- Erythema scores: no
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method:
- Criteria used to consider a positive response: Preliminary test: A mean ear thickness increase of equal to or greater than 25% was considered to indicate excessive irritation and limited biological relevance to the endpoint of sensitization.
Main test: The test item will be regarded as a sensitizer if at least one concentration of the test item results in a threefold or greater increase in 3HTdR incorporation compared to control values. Any test item failing to produce a threefold or greater increase in 3HTdR incorporation will be classified as a "non-sensitizer".
TREATMENT PREPARATION AND ADMINISTRATION: - Positive control substance(s):
- other: Phenylacetaldehyde
- Statistics:
- Data was processed to give group mean values for disintegrations per minute and standard deviations where appropriate. Individual and group mean disintegrations per minute values were assessed for dose response relationships. Data was first assessed for suitability by analysis of normality and homogeneity of variance. If the assumptions that the data are both normally distributed and has homogeneity of variances, then parametric one way analysis of variance (ANOVA) and Dunnett’s multiple comparison procedure were used to determine
statistical significance. If the assumptions were not met, non-parametric Kruskal-Wallis Rank Sum and Mann-Whitney U test procedures were used. - Positive control results:
- The positive control Phenylacetaldehyde (>90%) gave a Stimulation Index of greater than 3 (15.12) when tested at a concentration of 5% v/v in propylene glycol, thus, demonstrating the sensitivity and reliability of the test system.
- Key result
- Parameter:
- SI
- Value:
- > 0.92 - < 1.77
- Test group / Remarks:
- Overall range from all test groups
- Key result
- Parameter:
- SI
- Remarks:
- 5%
- Value:
- > 0.92 - <= 1.77
- Key result
- Parameter:
- SI
- Remarks:
- 10%
- Value:
- > 0.92 - <= 1.77
- Key result
- Parameter:
- SI
- Remarks:
- 2.5%
- Value:
- > 0.92 - <= 1.77
- Cellular proliferation data / Observations:
DETAILS ON STIMULATION INDEX CALCULATION The Stimulation Index expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group
Body weight change of the test animals between Day 1 and Day 6 was comparable to that observed in the corresponding control group animals over the same period.
There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test.- Interpretation of results:
- GHS criteria not met
- Remarks:
- non-sensitizer
- Conclusions:
- The test item was considered to be a non-sensitizer under the conditions of the test.
The positive control Phenylacetaldehyde (>90%) gave a Stimulation Index of greater than 3 (15.12) when tested at a concentration of 5% v/v in propylene glycol, thus, demonstrating the sensitivity and reliability of the test system. - Executive summary:
A study was performed to assess the skin sensitization potential of the test item in the CBA/Ca strain mouse following topical application to the dorsal surface of the ear.
Following a preliminary screening test in which no clinical signs of toxicity were noted at a maximum attainable concentration of 10% w/w, this concentration was selected as the highest dose investigated in the main test of the Local Lymph Node Assay. Three groups, each of five animals, were treated with 50 μL (25 μL per ear) of the test item as a suspension in propylene glycol at concentrations of 10%, 5% or 2.5% w/w. A further group of five animals was treated with propylene glycol alone. A concurrent positive control test, using a group of five animals, was also performed with the known sensitizer, Phenylacetaldehyde (>90%), at a concentration of 5% v/v in propylene glycol.
The Stimulation Index expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group.
The test item was considered to be a non-sensitizer under the conditions of the test. The positive control Phenylacetaldehyde (>90%) gave a Stimulation Index of greater than 3 (15.12) when tested at a concentration of 5% v/v in propylene glycol, thus, demonstrating the sensitivity and reliability of the test system.
Reference
Estimation of the Proliferative Response of Lymph Node Cells - Stimulation Index
Concentration in propylene glycol | Stimulation Index | Result |
RD 14156 2.5% w/w | 0.92 | Negative |
RD 14156 5% w/w | 1.29 | Negative |
RD 14156 10% w/w | 1.77 | Negative |
Positive control 5% v/v | 15.12 | Positive |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test. Body weight change of the test animals between Day 1 and Day 6 was comparable to that observed in the corresponding control group animals over the same period.
Stimulation index was <3 at all three test concentrations (SI 0.92 at 2.5%, SI 1.29 at 5% and SI 1.77 at 10%)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The substance has been tested and found not to be a skin sensitzer with a Stimulation index of <3.
In accordance with the classifciation criteria described in CLP Regulation 1272/2008 the substance is not classified for skin sensitization.
No information is available for respiratory sensitization however, the substance is a waxy solid with a low vapour pressure and therefore respiratory sensitization is considered unlikely.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.